19-52574106-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001172655.1(ZNF701):c.157G>A(p.Glu53Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000763 in 1,612,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001172655.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF701 | NM_018260.3 | c.-42G>A | 5_prime_UTR_variant | 2/4 | ENST00000391785.8 | NP_060730.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF701 | ENST00000391785 | c.-42G>A | 5_prime_UTR_variant | 2/4 | 1 | NM_018260.3 | ENSP00000375662.2 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 151878Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000719 AC: 18AN: 250514Hom.: 0 AF XY: 0.0000812 AC XY: 11AN XY: 135448
GnomAD4 exome AF: 0.0000712 AC: 104AN: 1460168Hom.: 0 Cov.: 30 AF XY: 0.0000867 AC XY: 63AN XY: 726410
GnomAD4 genome AF: 0.000125 AC: 19AN: 151996Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74246
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2024 | The c.157G>A (p.E53K) alteration is located in exon 3 (coding exon 2) of the ZNF701 gene. This alteration results from a G to A substitution at nucleotide position 157, causing the glutamic acid (E) at amino acid position 53 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at